Skip to main content
The New England Journal of Medicine publishes a Groundbreaking Study of Our Investigational Drug, Epidiolex® (cannabidiol).
May 24, 2017
Greenwich partners with Childhood Neurology Foundation and Indiana University to improve communication between neurologists and families of children living with epilepsy
The Food and Drug Administration (FDA) Accepts the NDA Filing of Epidioloex® (cannabidiol) for Priority Review
Greenwich Biosciences Sponsors Several Activities at the 2017 American Epilepsy Society Meeting
Greenwich Biosciences Is Proud To Recognize International Dravet Syndrome Awareness Day